This Medudy Master Class Series with Prof. Sherko Kümmel is a video tutorial for physicians on the topic of "Treatment of triple-negative breast cancer".
Part 6 of the tutorial concentrates on the therapy management of antibody-drug conjugates (ADC). The focus is on the use and handling of substances such as sacituzumab-govitecan and trastuzumab-deruxtecan. The tutorial also provides detailed information on the management of side effects of these agents
Note: All "speakers" appearing in the Medudy videos are AI-based avatars used to improve the didactics of the videos. The people on whom the avatars are based have explicitly consented to their use. All content is based on high-quality scientific sources and is created and reviewed by the Medudy medical team.
The course was created with the kind support of Gilead Science and MSD.
At the end of this training you will know:
- the components (antibody, linker, cytotoxic payload) and the mechanism of action of antibody-drug conjugates (ADCs) in general
- the specific side effect profiles of the relevant ADCs
- Strategies and recommendations for the management and prophylaxis of ADC-specific toxicities
